title: [Overview of the Ebola vaccines in pre-clinical and clinical development].
abstract: The Ebola epidemic that occurred in West Africa between 2013-2016 significantly accelerated the research and development of Ebola vaccines. Few dozens of clinical trials have been recently conducted leading to opportunities to test several new vaccine candidates. Other vaccines are still in early development phases (table 1). This paper provides an overview of the new developments in that area.
authors.affiliation: GSK Vaccines R&D, 150 Beach Road, unit 22-00, 189720, Singapore, Singapore. philippe.x.buchy@gsk.com.
authors.forename: P
authors.initials: P
authors.lastname: Buchy
mesh_terms: D000354:Africa, Western / Q000453:epidemiology; D002986:Clinical Trials as Topic; D046129:Ebola Vaccines / Q000145:classification* / Q000627:therapeutic use*; D029043:Ebolavirus / Q000276:immunology; D019142:Hemorrhagic Fever, Ebola / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D014779:Virus Replication / Q000276:immunology
chemical_list: D046129:Ebola Vaccines
keywords: Ebola; Non-replicative viral vaccines; Replicative viral vaccines; Review; Vaccine